The tumor suppressor CYLD is a deubiquitinating enzyme, acts as a negative regulator of NF-kappa-B signaling, and plays a pro-inflammatory role in vascular smooth muscle cells [10]. The gene discussed is CYLD; the disease is neoplasm.